Quantum Biopharma Ltd. Share Price Today: Live Updates & Key Insights
Quantum Biopharma Ltd. share price today is $2.28, up -5.08%. The stock opened at $2.26 against the previous close of $2.36, with an intraday high of $2.29 and low of $2.2.
Quantum Biopharma Ltd. Share Price Chart
Quantum Biopharma Ltd.
Quantum Biopharma Ltd. Share Price Performance
Quantum Biopharma Ltd. Institutional Holdings
Quantum Biopharma Ltd. Market Status
Quantum Biopharma Ltd. Fundamentals
Market Cap 8.61 M
PB Ratio 0.9772
PE Ratio 0.0
Enterprise Value 10.18 M
Total Assets 17.12 M
Volume 73081
Quantum Biopharma Ltd. Company Financials
About Quantum Biopharma Ltd. & investment objective
Company Information Quantum BioPharma Ltd., together with its subsidiaries, operates as a biopharmaceutical company. It operates through two segments, Biopharmaceutical Innovation and Strategic Investments. The company researches and develops a portfolio of assets and biotech solutions for the treatment of neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. Its lead compound is Lucid-MS, a patented new chemical entity that is in Phase 2 clinical trial to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. It also develops FSD-PEA, which is in preparation for Phase 2 trial for the treatment of inflammatory diseases, such as mast cell activation syndrome; Lucid-PSYCH to treat major depressive disorder; and unbuzzd, a dietary supplement for the treatment of alcohol misuse. In addition, the company maintains a portfolio of strategic investments comprising loans secured by residential property. The company was formerly known as FSD Pharma Inc. and changed its name to Quantum BioPharma Ltd., in August 2024. Quantum BioPharma Ltd. was founded in 1998 and is headquartered in Toronto, Canada.
Organisation Biotechnology
Employees 0
Industry Biotechnology
CEO Mr. Zeeshan Saeed
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Quantum Biopharma Ltd. FAQs
What is the share price of Quantum Biopharma Ltd. today?
The current share price of Quantum Biopharma Ltd. is $2.28.
Can I buy Quantum Biopharma Ltd. shares in India?
Yes, Indian investors can buy Quantum Biopharma Ltd. shares by opening an international trading and demat account with Motilal Oswal.
How to buy Quantum Biopharma Ltd. shares in India?
You can easily invest in Quantum Biopharma Ltd. shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Quantum Biopharma Ltd. shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Quantum Biopharma Ltd..
Can I buy fractional shares of Quantum Biopharma Ltd.?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Quantum Biopharma Ltd.?
Quantum Biopharma Ltd. has a market cap of $8.61 M.
In which sector does Quantum Biopharma Ltd. belong?
Quantum Biopharma Ltd. operates in the Biotechnology sector.
What documents are required to invest in Quantum Biopharma Ltd. stocks?
To invest, you typically need:
What is the PE and PB ratio of Quantum Biopharma Ltd.?
The PE ratio of Quantum Biopharma Ltd. is N/A and the PB ratio is 0.98.